Identification of Host and Viral Determinants of Human Norovirus B cell Infection
Identification of Host and Viral Determinants of Human Norovirus B cell Infection
批准号:
10062847
负责人:
Stephanie M Karst
金额:
$47.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-12-01 至 2022-11-30
关键词:
Antiviral AgentsAttenuated VaccinesB-Lymphocyte SubsetsB-LymphocytesBile AcidsCRISPR/Cas technologyCell Culture SystemCell Culture TechniquesCell CycleCellsCessation of lifeChildChildhoodClinic VisitsClone CellsCommunitiesDevelopmentDiagnosticDiarrheaDiseaseDisease OutbreaksDrug TargetingG1 PhaseGastroenteritisGenerationsGenomeGenotypeHeparitin SulfateHepatitis C virusHumanIn VitroInfectionIntegration Host FactorsInterferonsInterventionIntestinesKnock-outLaboratoriesLeadLibrariesMediatingMolecularMutationNorovirusPharmaceutical PreparationsPhenotypePovertyPredispositionPrevention strategyProductionPropertyProteinsPublishingRecording of previous eventsReportingResearchScienceSerial PassageSupport SystemSurfaceSurveysSystemTestingTextTimeUnited StatesVaccinesViralViral AntibodiesViral GenomeVirusVirus Replicationanti-hepatitis Ccell typecommensal bacteriadiagnostic platformdiarrheal diseaseexperimental studyfitnessfoodborne illnessgenome-wideimprovedin vivoinfected B cellinnovationinsightnovelnovel therapeuticspandemic diseasepreventresponsereverse geneticstherapeutic developmenttoolvaccine candidatevirus host interaction
中文摘要
摘要
人类诺如病毒是儿童严重腹泻和胃肠炎暴发的主要全球原因。
然而,治疗和预防策略的发展受到了严重限制,因为无法
在培养中繁殖这些病毒。我们最近发现诺如病毒在体外和体内感染B细胞,
他们利用共生细菌作为感染的辅助因素。这些新颖的发现直接导致了我们的
开发第一个人类诺沃克病毒培养系统,这是一个将给诺沃克病毒研究带来革命性变化的工具。
我们现在独一无二地准备识别影响人类的寄主限制和易感因素
诺如病毒感染B细胞以及B细胞感染的病毒决定因素。我们假设这是
信息将揭示关键的病毒-宿主相互作用,这些信息可以指导新疗法的开发,
候选疫苗,以及增强的诊断策略。在具体目标1中,我们将利用互补
有针对性和不偏不倚的方法,以制定一套全面的主机因素集,以限制或
促进人诺如病毒感染B细胞。在具体目标2中,将采取多管齐下的办法
确定体外复制适合性的病毒决定因素。策略包括病毒在中国的连续传播
并测试一组不同的人类诺沃克病毒基因型别的B细胞感染性。我们还将
构建人诺如病毒反向遗传学系统,以测试适应性突变的表型效应。这些
研究不仅将为人类感染B细胞的宿主和病毒决定因素提供重要的洞察力
诺如病毒,但它们也应该在第二代培养系统的开发中达到顶峰,以支持
广泛的病毒基因型别的强大感染。
英文摘要
SUMMARY
Human noroviruses are a leading global cause of severe childhood diarrhea and gastroenteritis outbreaks.
However, development of therapeutic and preventative strategies has been severely limited by the inability to
propagate these viruses in culture. We recently discovered that noroviruses infect B cells in vitro and in vivo,
and that they utilize commensal bacteria as a co-factor for infection. These novel findings led directly to our
development of the first human norovirus cultivation system, a tool that will revolutionize norovirus research.
We are now uniquely poised to identify host restriction and susceptibility factors influencing human
norovirus infection of B cells as well as viral determinants of B cell infection. We hypothesize that this
information will reveal key virus-host interactions that can guide the development of novel therapeutics,
vaccine candidates, and enhanced diagnostic strategies. In Specific Aim 1, we will utilize complementary
targeted and unbiased approaches to develop a comprehensive set of host factors that either restrict or
promote human norovirus infection of B cells. In Specific Aim 2, a multi-pronged approach will be undertaken
to identify viral determinants of in vitro replicative fitness. Strategies include serial passaging of virus in
permissive cells and testing a diverse set of human norovirus genotypes for B cell infectivity. We will also
construct a human norovirus reverse genetics system to test adaptive mutations for phenotypic effects. These
studies will not only provide critical insight into host and viral determinants of B cell infection by human
noroviruses but they should also culminate in the development of 2nd generation culture systems supporting
robust infection of a broad panel of viral genotypes.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1038/s41564-017-0057-7
发表时间:
2017-12
期刊:
Nature microbiology
影响因子:
28.3
作者:
[Grau KR, Roth AN, Zhu S, Hernandez A, Colliou N, DiVita BB, Philip DT, Riffe C, Giasson B, Wallet SM, Mohamadzadeh M, Karst SM]
通讯作者:
Karst SM
DOI:
10.1186/s13073-022-01013-1
发表时间:
2022-01-27
期刊:
Genome medicine
影响因子:
12.3
作者:
[Grodzki M, Bluhm AP, Schaefer M, Tagmount A, Russo M, Sobh A, Rafiee R, Vulpe CD, Karst SM, Norris MH]
通讯作者:
Norris MH
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
-
批准号:10624395
-
项目类别:
-
资助金额:$60.4万
-
财政年份:2021
-
负责人:Stephanie M Karst
-
依托单位:
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
-
批准号:10413248
-
项目类别:
-
资助金额:$60.4万
-
财政年份:2021
-
负责人:Stephanie M Karst
-
依托单位:
Elucidation of Pathogenic Mechanisms underlying Norovirus Diarrhea
-
批准号:10277083
-
项目类别:
-
资助金额:$60.4万
-
财政年份:2021
-
负责人:Stephanie M Karst
-
依托单位:
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids
-
批准号:10061535
-
项目类别:
-
资助金额:$53.74万
-
财政年份:2018
-
负责人:Stephanie M Karst
-
依托单位:
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids
-
批准号:10517512
-
项目类别:
-
资助金额:$53.74万
-
财政年份:2018
-
负责人:Stephanie M Karst
-
依托单位:
Suppression of Enteric Norovirus Infection by Microbiota-Regulated Bile Acids
-
批准号:10289716
-
项目类别:
-
资助金额:$53.74万
-
财政年份:2018
-
负责人:Stephanie M Karst
-
依托单位:
Role of Intestinal Bacteria in Human Norovirus Infection
-
批准号:9208092
-
项目类别:
-
资助金额:$36.91万
-
财政年份:2015
-
负责人:Stephanie M Karst
-
依托单位:
Role of Intestinal Bacteria in Human Norovirus Infection
-
批准号:9416071
-
项目类别:
-
资助金额:$36.88万
-
财政年份:2015
-
负责人:Stephanie M Karst
-
依托单位:
Role of Intestinal Bacteria in Human Norovirus Infection
-
批准号:8863018
-
项目类别:
-
资助金额:$36.96万
-
财政年份:2015
-
负责人:Stephanie M Karst
-
依托单位:
Lack of protective immunity to murine norovirus infection
-
批准号:8263416
-
项目类别:
-
资助金额:$32.14万
-
财政年份:2010
-
负责人:Stephanie M Karst
-
依托单位:
Persistent norovirus infection impairs protective immunity
-
批准号:7788717
-
项目类别:
-
资助金额:$21.98万
-
财政年份:2010
-
负责人:Stephanie M Karst
-
依托单位:
Lack of protective immunity to murine norovirus infection
-
批准号:7884931
-
项目类别:
-
资助金额:$8.35万
-
财政年份:2010
-
负责人:Stephanie M Karst
-
依托单位:
Lack of protective immunity to murine norovirus infection
-
批准号:8298615
-
项目类别:
-
资助金额:$32.07万
-
财政年份:2010
-
负责人:Stephanie M Karst
-
依托单位:
Lack of protective immunity to murine norovirus infection
-
批准号:8485518
-
项目类别:
-
资助金额:$30.06万
-
财政年份:2010
-
负责人:Stephanie M Karst
-
依托单位:
LSUHSC COBRE: NOROVIRUS IMMUNITY AND PATHOGENESIS
-
批准号:8167461
-
项目类别:
-
资助金额:$20.99万
-
财政年份:2010
-
负责人:Stephanie M Karst
-
依托单位:
Persistent norovirus infection impairs protective immunity
-
批准号:8069540
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2010
-
负责人:Stephanie M Karst
-
依托单位:
Lack of protective immunity to murine norovirus infection
-
批准号:8259579
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2010
-
负责人:Stephanie M Karst
-
依托单位:
Lack of protective immunity to murine norovirus infection
-
批准号:7923648
-
项目类别:
-
资助金额:$32.96万
-
财政年份:2009
-
负责人:Stephanie M Karst
-
依托单位:
LSUHSC COBRE: NOROVIRUS IMMUNITY AND PATHOGENESIS
-
批准号:7959551
-
项目类别:
-
资助金额:$21.13万
-
财政年份:2009
-
负责人:Stephanie M Karst
-
依托单位:
LSUHSC COBRE: REPLICATION OF MURINE NOROVIRUS 1, MNV-1
-
批准号:7720568
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2008
-
负责人:Stephanie M Karst
-
依托单位:
海外基金